thyroxine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 22 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Despite severe thyrotoxicosis, combined IFN-alpha and ribavirin therapy was continued and radioiodine treatment was considered for Graves' disease." | 3.74 | IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report. ( Duncea, I; Pepene, CE, 2008) |
| " Latent hypothyroidism subsequently developed, but L-thyroxine therapy resulted in a rapid normalization of thyroid function tests." | 3.69 | Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C. ( D'Urso, R; Falaschi, P; Martocchia, A; Proietti, A, 1997) |
| "Thyrotoxicosis was most strongly associated with a lower pretreatment TSH (OR = 4." | 2.77 | Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex. ( Ghazarian, SR; Ladenson, PW; Mammen, JS; Pulkstenis, E; Rosen, A; Subramanian, GM, 2012) |
| "A 29-year-old, Caucasian woman with type 1 diabetes and hepatitis C virus infection was referred with hyperthyroidism, while she was at 17 weeks of a planned 24-week course of interferon alpha therapy." | 1.43 | Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report. ( Bajwa, H; Buch, HN; Gill, G; Strouhal, P, 2016) |
| "Each case of hyperthyroidism has to be precisely evaluated." | 1.30 | [Hepatitis C virus infection and thyroid diseases]. ( Bailly, F; Broussolle, C; Steineur, MP; Trépo, C; Zoulim, F, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (50.00) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Cristinel Badiu, D | 1 |
| Popescu, GC | 1 |
| Zgura, A | 1 |
| Mercan Stanciu, A | 1 |
| Dodot, MD | 1 |
| Mehedintu, C | 1 |
| Toma, L | 1 |
| Razvan, S | 1 |
| Bacinschi, X | 1 |
| Haineala, B | 1 |
| Batool, N | 1 |
| Elahi, S | 2 |
| Saleem, N | 1 |
| Ashraf, A | 1 |
| Mammen, JS | 2 |
| Ghazarian, SR | 2 |
| Rosen, A | 2 |
| Ladenson, PW | 2 |
| Andreoli, MT | 1 |
| Lim, JI | 1 |
| Shafiq, MI | 1 |
| Gauhar, A | 1 |
| Akram, M | 1 |
| Gill, G | 1 |
| Bajwa, H | 1 |
| Strouhal, P | 1 |
| Buch, HN | 1 |
| Duncea, I | 1 |
| Pepene, CE | 1 |
| Pulkstenis, E | 1 |
| Subramanian, GM | 1 |
| Acquaviva, A | 1 |
| Municchi, G | 1 |
| Marconcini, S | 1 |
| D'Ambrosio, A | 1 |
| Morgese, G | 1 |
| Braga-Basaria, M | 1 |
| Basaria, S | 1 |
| Afhami, S | 1 |
| Haghpanah, V | 1 |
| Heshmat, R | 1 |
| Rasoulinejad, M | 1 |
| Izadi, M | 1 |
| Lashkari, A | 1 |
| Tavangar, SM | 1 |
| Hajiabdolbaghi, M | 1 |
| Mohraz, M | 1 |
| Larijani, B | 1 |
| Kamikubo, K | 1 |
| Takami, R | 1 |
| Suwa, T | 1 |
| Kawase, Y | 1 |
| Shiroko, J | 1 |
| Kametani, M | 1 |
| Tokimitsu, N | 1 |
| Sakata, S | 1 |
| Eugène, C | 1 |
| Tennenbaum, R | 1 |
| Anciaux, ML | 1 |
| Quevauvilliers, J | 1 |
| Bergue, A | 1 |
| Marazuela, M | 1 |
| García-Buey, L | 1 |
| González-Fernández, B | 1 |
| García-Monzón, C | 1 |
| Arranz, A | 1 |
| Borque, MJ | 1 |
| Moreno-Otero, R | 1 |
| Sato, K | 1 |
| Miyakawa, M | 1 |
| Demura, H | 1 |
| Martín-Vivaldi, R | 1 |
| Nogueras, F | 1 |
| Quintero, D | 1 |
| Espinosa, MD | 1 |
| López de Hierro, M | 1 |
| Suárez, JF | 1 |
| González, A | 1 |
| Nagai, Y | 1 |
| Ohsawa, K | 1 |
| Ieki, Y | 1 |
| Kobayashi, K | 1 |
| Falaschi, P | 2 |
| D'Urso, R | 2 |
| Proietti, A | 2 |
| Martocchia, A | 2 |
| Pastore, R | 1 |
| Angelucci, L | 1 |
| Mabe, K | 1 |
| Shinzawa, H | 1 |
| Yamatani, K | 1 |
| Takeda, T | 1 |
| Ishibashi, M | 1 |
| Yamada, N | 1 |
| Misawa, H | 1 |
| Wakabayashi, H | 1 |
| Togashi, H | 1 |
| Takahashi, T | 1 |
| Broussolle, C | 1 |
| Steineur, MP | 1 |
| Bailly, F | 1 |
| Zoulim, F | 1 |
| Trépo, C | 1 |
| Marcellin, P | 1 |
| Pouteau, M | 1 |
| Renard, P | 1 |
| Grynblat, JM | 1 |
| Colas Linhart, N | 1 |
| Bardet, P | 1 |
| Bok, B | 1 |
| Benhamou, JP | 1 |
2 trials available for thyroxine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
Topics: Adult; Antiviral Agents; Asia; Biomarkers; Chi-Square Distribution; Europe; Female; Hepatitis C; Hum | 2013 |
Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Topics: Adult; Antiviral Agents; Cohort Studies; Delayed-Action Preparations; Female; Hepatitis C; Humans; H | 2012 |
20 other studies available for thyroxine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing.
Topics: Adult; Aged; COVID-19; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Hypothyroidism; | 2021 |
Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area.
Topics: Adult; Female; Hepatitis C; Humans; Hypothyroidism; Incidence; Male; Middle Aged; Thyrotropin; Thyro | 2017 |
Cotton-wool spots and retinal hemorrhages. Interferon-associated retinopathy.
Topics: Anemia; Antiviral Agents; Female; Hepatitis C; Humans; Hypothyroidism; Interferon-alpha; Middle Aged | 2014 |
Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan.
Topics: Adolescent; Adult; Antibodies; Child; Child, Preschool; Female; Hepacivirus; Hepatitis C; Humans; Hy | 2015 |
Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
Topics: Adult; Amenorrhea; Antiviral Agents; Diabetes Mellitus, Type 1; Female; Hepatitis C; Humans; Hyperth | 2016 |
IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report.
Topics: Antiviral Agents; Drug Therapy, Combination; Graves Disease; Hepatitis C; Humans; Interferon-alpha; | 2008 |
Celiac disease in a patient with beta-thalassemia major.
Topics: beta-Thalassemia; Blood Transfusion; Celiac Disease; Follow-Up Studies; Glutens; Hepatitis C; Humans | 2003 |
Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves' disease.
Topics: Antiviral Agents; Female; Graves Disease; Hepatitis C; Humans; Hypothyroidism; Interferon alpha-2; I | 2003 |
Assessment of the factors involving in the development of hypothyroidism in HIV-infected patients: a case-control study.
Topics: Adult; Age Factors; Antiretroviral Therapy, Highly Active; Case-Control Studies; CD4 Lymphocyte Coun | 2007 |
Case report: silent thyroiditis developed during alpha-interferon therapy.
Topics: Adult; Female; Goiter; Hepatitis C; Humans; Interferon Type I; Radionuclide Imaging; Recombinant Pro | 1993 |
[Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].
Topics: Adult; Autoimmune Diseases; Carbimazole; Female; Hepatitis C; Humans; Hyperthyroidism; Hypothyroidis | 1993 |
Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Topics: Adult; Aged; Autoantibodies; Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferon-alpha; Male | 1996 |
Reversible, extremely severe hypothyroidism in a patient with chronic hepatitis C treated with interferon-alpha.
Topics: Female; Hepatitis C; Humans; Hypothyroidism; Interferon-alpha; Middle Aged; Myxedema; Thyroglobulin; | 1996 |
[Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Topics: Adult; Antiviral Agents; Female; Hepatitis C; Hepatitis, Chronic; Humans; Hypothyroidism; Interferon | 1996 |
Effect of interferon-beta on thyroid function in patients of chronic hepatitis C without preexisting autoimmune thyroid disease.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C; Humans; Immunoassay; Immunoenzyme Techniques; In | 1996 |
Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis.
Topics: Adult; Aged; Autoantibodies; Female; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Interfero | 1997 |
Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C.
Topics: Adult; Biopsy, Needle; Chronic Disease; Female; Hepatitis C; Humans; Hypothyroidism; Interferon-alph | 1997 |
Case report: interferon induced coma in Sheehan's syndrome.
Topics: Adrenocorticotropic Hormone; Chronic Disease; Coma; Electrolytes; Female; Hepatitis C; Humans; Hydro | 1997 |
[Hepatitis C virus infection and thyroid diseases].
Topics: Adult; Antiviral Agents; Autoantibodies; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C, | 1999 |
Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.
Topics: Adult; Chronic Disease; Female; Hepatitis C; Humans; Hypothyroidism; Interferon Type I; Recombinant | 1992 |